Vaccine News and Research

Latest Vaccine News and Research

New insight into role of autophagy in controlling SARS-CoV-2 infection

A team of researchers at the University of Manitoba in Canada said that nanoparticle targeting of autophagy at the sites could be a potent tool to effectively overcome COVID-19 while preventing the common adverse effects of the drug.

2 Dec 2020

Immune system differences, better blood vessel health could protect children from severe COVID-19

Differences in the immune systems and better blood vessel health were among the factors protecting children from severe COVID-19, according to a new review.

2 Dec 2020

CDC to reduce quarantine period from 14 days to 7 to 10 days

The U.S. Centers for Disease Control and Prevention (CDC), along with other health agencies such as the World Health Organization (WHO), recommend that people who may have been in close contact with a coronavirus disease (COVID-19) case should undergo quarantine for 14 days.

2 Dec 2020

The UK approves Pfizer vaccine for December 2020 roll out

The UK approves Pfizer vaccine and schedules phased vaccination process, commencing December 2020.

2 Dec 2020

Brown researchers receive federal grant to track adverse impacts of vaccines in elderly residents

As the U.S. moves toward the highly anticipated approval of the first COVID-19 vaccines, residents of nursing homes and other long-term care facilities are likely to join health care workers as groups who will be among the earliest vaccine recipients in most states.

2 Dec 2020

COVID-19-related disruptions to cervical cancer screening could increase risk sevenfold, UK case study finds

A new study reveals inequalities in the delay in screening for cervical cancer, and recommends that the screening capacity be increased in addition to giving a higher priority to women who have missed their scheduled visit.

2 Dec 2020

Modeling study predicts 90 percent drop in COVID-19 deaths following vaccination in US

A new modeling study of the United States suggests that vaccination could markedly reduce the rate of infection, hospitalizations and mortality in the current COVID-19 pandemic – even if confined to adults alone.

2 Dec 2020

UTHSC receives $1.25 million to conduct a study on improving adherence to HPV vaccine

The human papillomavirus (HPV) vaccine was introduced in the United States for preteens more than a dozen years ago, yet adherence rates are still below those for other childhood vaccines.

2 Dec 2020

A new potential COVID-19 vaccine candidate: YF-S0

A recent study published in the journal Nature describes the safety and efficacy of a live-attenuated yellow fever 17D (YF17D) vector-based vaccine candidate expressing a non-cleavable form of the spike protein of severe acute respiratory coronavirus 2 (SARS-CoV2).

2 Dec 2020

SARS-CoV-2 deletion mutations may have attenuated infectivity in some strains

A team of researchers at the University of Hong Kong has identified a panel of SARS-CoV-2 variants, called Del-mut, which contains a deletion in the S1/S2 junction. Upon investigating one of the deleted variants in animal models, they found that Del-mut-1 is attenuated in its ability to cause disease or pathological changes.

2 Dec 2020

Mobile health app can improve HPV vaccine uptake in adolescents

More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals.

2 Dec 2020

Researchers evaluate the most appropriate test for COVID-19

Until a vaccine is available, curbing the coronavirus pandemic relies heavily on how quickly a potentially exposed individual can be tested and quarantined.

2 Dec 2020

Study evaluates the performance of meningococcus B vaccine in real-world setting

Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero.

2 Dec 2020

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.

1 Dec 2020

Nanomedicine's giant step into the fight against the COVID-19

A recent editorial in Nature Nanotechnology discusses the enormous feat of scientific innovation, with messenger RNA (mRNA)-based vaccines developed to deliver the gene sequence of specific SARS-CoV-2 viral proteins into host cells using nanotechnology platforms.

1 Dec 2020

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

Researchers in Algeria have reviewed some of the evidence suggesting that flavonols commonly found in many plants and vegetables could be used as a therapeutic approach to coronavirus disease 2019 (COVID-19).

1 Dec 2020

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against Covid-19 based on the yellow fever vaccine, which as a result also works against yellow fever. Results published today in Nature show that the vaccine protects hamsters from infection with the SARS-CoV-2 coronavirus after a single dose.

1 Dec 2020

Low endorsement among doctors worldwide for COVID-19 ‘immunity passports’

A cross-sectional survey conducted in September 2020, aimed at assessing the views of a randomly selected, stratified physician sample on this matter, drawing names from physicians registered with the global networking platform called Sermo. This offers its registration service to verified licensed physicians.

1 Dec 2020

Study demonstrates safety of novel immuno-oncology therapy in patients with advanced solid tumors

A novel therapy designed to help stimulate the body's immune system response against cancer appears to be safe to use as alone or in combination with immune checkpoint inhibitors.

1 Dec 2020

New reviews provide timely updates for scholars, professionals focused on antimicrobial research

The initial chapter of 'Anti-infective Research and Development: Updates on Infection Mechanisms and Treatments' covers the mode of action of natural antimycobacterial compounds such as nordihydroguaiaretic acid, α-mangostin and allicin, as well as antimicrobial peptides and their role in the innate and adaptive immune response leading to the decrease of microbial resistance.

1 Dec 2020

Vaccine News and Research

Latest Vaccine News and Research

New insight into role of autophagy in controlling SARS-CoV-2 infection

Immune system differences, better blood vessel health could protect children from severe COVID-19

CDC to reduce quarantine period from 14 days to 7 to 10 days

The UK approves Pfizer vaccine for December 2020 roll out

Brown researchers receive federal grant to track adverse impacts of vaccines in elderly residents

COVID-19-related disruptions to cervical cancer screening could increase risk sevenfold, UK case study finds

Modeling study predicts 90 percent drop in COVID-19 deaths following vaccination in US

UTHSC receives $1.25 million to conduct a study on improving adherence to HPV vaccine

A new potential COVID-19 vaccine candidate: YF-S0

SARS-CoV-2 deletion mutations may have attenuated infectivity in some strains

Mobile health app can improve HPV vaccine uptake in adolescents

Researchers evaluate the most appropriate test for COVID-19

Study evaluates the performance of meningococcus B vaccine in real-world setting

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

Nanomedicine's giant step into the fight against the COVID-19

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

Low endorsement among doctors worldwide for COVID-19 ‘immunity passports’

Study demonstrates safety of novel immuno-oncology therapy in patients with advanced solid tumors

New reviews provide timely updates for scholars, professionals focused on antimicrobial research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in